<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Pneumothorax: Definitive management and prevention of recurrence
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Pneumothorax: Definitive management and prevention of recurrence
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Pneumothorax: Definitive management and prevention of recurrence
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            YC Gary Lee, MBChB, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            V Courtney Broaddus, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Geraldine Finlay, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Sep 26, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H899018083">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pneumothorax (gas in the pleural space) is considered spontaneous when it presents in the absence of an external factor. Primary spontaneous pneumothorax (PSP) presents in the absence of clinical lung disease while secondary spontaneous pneumothorax (SSP) presents as a complication of underlying lung disease or injury  (
         <a class="graphic graphic_table graphicRef120903" href="/z/d/graphic/120903.html" rel="external">
          table 1
         </a>
         ). The recurrence rate and therefore management strategies of PSP and SSP differ in their timing and threshold to perform a definitive procedure to prevent recurrence.
        </p>
        <p>
         The definitive management and prevention of recurrent pneumothorax is discussed in this topic review. Our approach expands upon that outlined in published clinical consensus statements and guidelines from The American College of Chest Physicians (2001), British Thoracic Society (2010), European Respiratory Society (2015), the Japanese Association for Chest Surgery (2014), and others [
         <a href="#rid1">
          1-6
         </a>
         ]. The epidemiology and etiology, clinical presentation and diagnosis, and initial management of pneumothorax are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6706.html" rel="external">
          "Pneumothorax in adults: Epidemiology and etiology"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/117242.html" rel="external">
          "Clinical presentation and diagnosis of pneumothorax"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/117232.html" rel="external">
          "Treatment of primary spontaneous pneumothorax in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6691.html" rel="external">
          "Treatment of secondary spontaneous pneumothorax in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2031838821">
         <span class="h1">
          INCIDENCE OF RECURRENCE
         </span>
        </p>
        <p class="headingAnchor" id="H911125560">
         <span class="h2">
          Primary spontaneous pneumothorax
         </span>
         <span class="headingEndMark">
          —
         </span>
         The estimated recurrence rate after the first primary spontaneous pneumothorax (PSP) is broad, ranging from 0 to 60 percent; however, newer studies suggest average recurrence rates between 10 and 30 percent at one to five year follow-up period, with the highest risk occurring in the first 30 days through the first year [
         <a href="#rid1">
          1,2,7-9
         </a>
         ]. In one of the largest epidemiologic studies of spontaneous pneumothorax, rates of recurrent PSP for males were 4 percent (&lt;7 days), 8 percent (&lt;30 days), 10 percent (&lt;3 months), 13 percent (&lt;1 year), and 20 percent (&lt;5 years) [
         <a href="#rid10">
          10
         </a>
         ]. Rates in females were similarly 5 percent (&lt;7 days), 9 percent (&lt;30 days), 11 percent (&lt;3 months), 15 percent (&lt;1 year), and 22 percent (&lt;5 years). However, these rates may have been underestimated since they were calculated from inpatient admissions and did not include patients treated as outpatients. In contrast, in another systematic review that included 29 randomized trials and observational series, the pooled one-year recurrence rate for patients with PSP was 29 percent [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
         Risk factors reported to be associated with an increased risk of recurrence include [
         <a href="#rid11">
          11-18
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Female sex
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tall stature in males
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Low body weight
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Failure to stop smoking or presence of respiratory bronchiolitis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Large initial pneumothorax size
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Blebs or bullae on chest computed tomography (CT) scan
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Previous events
        </p>
        <p>
        </p>
        <p>
         As an example, one study of 176 patients with PSP reported that the risk of ipsilateral recurrence for patients with blebs and bullae on chest CT was 68 percent compared with 6 percent in patients without blebs and bullae, with the highest risk in those with multiple and bilateral lesions (75 percent) [
         <a href="#rid13">
          13
         </a>
         ]. The risk of contralateral pneumothorax was also higher in patients with blebs and bullae on CT (19 versus 0 percent). (See
         <a class="medical medical_review" href="/z/d/html/6706.html" rel="external">
          "Pneumothorax in adults: Epidemiology and etiology", section on 'Primary spontaneous pneumothorax'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6706.html" rel="external">
          "Pneumothorax in adults: Epidemiology and etiology", section on 'Secondary spontaneous pneumothorax'
         </a>
         .)
        </p>
        <p>
         The broad range and high incidence of recurrence in subpopulations of patients with PSP, in particular those found to have blebs or bullae on imaging, has led some experts to propose that the classification of pneumothorax is not necessarily binary (primary versus secondary) but rather a continuum with risk of recurrence ranging from low to high. At minimum, a subpopulation of patients with suspected PSP based on the chest radiograph alone may actually have undiagnosed lung disease and this subpopulation may warrant reclassification as secondary spontaneous pneumothorax (SSP) so that appropriate preventions can be put in place. Future studies should focus on defining cutoffs for recurrence risk to distinguish those with high recurrence in whom pleurodesis is indicated after a first event from those with a low recurrence in whom pleurodesis is not justified until pneumothorax recurs. (See
         <a class="medical medical_review" href="/z/d/html/6706.html" rel="external">
          "Pneumothorax in adults: Epidemiology and etiology", section on 'Pathogenesis and risk factors'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H506255406">
         <span class="h2">
          Secondary spontaneous pneumothorax
         </span>
         <span class="headingEndMark">
          —
         </span>
         Data to support high recurrence rates in this population are largely derived from patients with chronic obstructive pulmonary disease (COPD). For example, one study reported a 50 percent likelihood of recurrent SSP over three years among patients with a pneumothorax due to COPD who did not have an intervention to prevent recurrence [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p>
         Similar high recurrence rates have been described in other populations of patients with acute and chronic lung disease including female patients with lymphangioleiomyomatosis and individuals with nontuberculous mycobacteria and Birt-Hogg-Dubé syndrome [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
         One of the largest epidemiologic studies of spontaneous pneumothorax suggested that the rates of recurrent SSP may be lower than originally thought [
         <a href="#rid10">
          10
         </a>
         ]; rates of recurrence for males were 7 percent (&lt;7 days), 14 percent (&lt;30 days), 20 percent (&lt;3 months), 27 percent (&lt;1 year), and 33 percent (&lt;5 years). Rates in females were similarly 6 percent (&lt;7 days), 13 percent (&lt;30 days), 19 percent (&lt;3 months), 25 percent (&lt;1 year), and 31 percent (&lt;5 years). However, these rates may have been underestimated since they were calculated from inpatient admissions over a 46-year period and adjustments for interventions was not clear. (See
         <a class="medical medical_review" href="/z/d/html/107651.html" rel="external">
          "Sporadic lymphangioleiomyomatosis: Clinical presentation and diagnostic evaluation", section on 'Pulmonary'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/100661.html" rel="external">
          "Birt-Hogg-Dubé syndrome", section on 'Pulmonary manifestations'
         </a>
         .)
        </p>
        <p>
         Risk factors for recurrence may be similar to those in patients with PSP (eg, smoking) [
         <a href="#rid14">
          14
         </a>
         ] (see
         <a class="local">
          'Primary spontaneous pneumothorax'
         </a>
         above) but are less well studied since most patients with SSP proceed with a definitive measure to prevent recurrence after their initial event.
        </p>
        <p class="headingAnchor" id="H622738162">
         <span class="h1">
          INDICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Once patients have undergone initial management for pneumothorax, clinicians should assess the risk of recurrence to evaluate whether definitive management (usually pleurodesis) is indicated. Several indications for the prevention of recurrence exist  (
         <a class="graphic graphic_algorithm graphicRef121365" href="/z/d/graphic/121365.html" rel="external">
          algorithm 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H622892173">
         <span class="h2">
          Primary spontaneous pneumothorax at high risk of recurrence
         </span>
         <span class="headingEndMark">
          —
         </span>
         Since the risk of recurrence is considered low in patients with primary spontaneous pneumothorax (PSP; ie, pneumothorax without underlying lung disorder), most patients with a first episode of PSP do
         <strong>
          not
         </strong>
         typically undergo definitive treatment
         <strong>
          until it recurs
         </strong>
         . However, a small percentage of patients need a definitive intervention even with a first episode. These include patients with a prolonged (persistent) air leak (PAL; typically defined as air leak &gt;5 days), patients with a high risk occupation or hobby (eg, airline pilot, deep sea diver), patients with contralateral, bilateral, or life-threatening PSP, and patients with a first contralateral pneumothorax, a high burden of cysts, desire to avoid recurrence, or undergoing thoracoscopy for another indication (eg, hemothorax, lung biopsy). Further details are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/117232.html" rel="external">
          "Treatment of primary spontaneous pneumothorax in adults", section on 'Indications for definitive procedure after first event'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6705.html" rel="external">
          "Pneumothorax and air travel"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/177.html" rel="external">
          "Complications of SCUBA diving"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1236434495">
         <span class="h2">
          First episode of secondary spontaneous pneumothorax
         </span>
         <span class="headingEndMark">
          —
         </span>
         Since the recurrence rate is considered high (eg, &gt;50 percent), most patients with a
         <strong>
          first
         </strong>
         episode of secondary spontaneous pneumothorax (SSP; ie, spontaneous pneumothorax due to underlying lung disorder) should undergo a definitive intervention to prevent recurrence. Individual exceptions may be applied to patients with very small loculated pneumothoraces (eg, patients with cystic fibrosis [
         <a href="#rid6">
          6
         </a>
         ]) or patients who decline definitive treatment. Further details are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/6691.html" rel="external">
          "Treatment of secondary spontaneous pneumothorax in adults", section on 'Preventing recurrence and follow-up'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1581026732">
         <span class="h2">
          Prolonged air leak
         </span>
         <span class="headingEndMark">
          —
         </span>
         Any pneumothorax that presents with a PAL beyond five days should be assessed for a definitive procedure based upon the rationale that the underlying defect is large and unlikely to heal rapidly on its own. In such cases a definitive procedure is both a therapeutic (to seal the leak) and a preventative measure. PALs are more commonly encountered in patients with SSP than PSP.
        </p>
        <p class="headingAnchor" id="H294808217">
         <span class="h2">
          Recurrent pneumothorax
         </span>
         <span class="headingEndMark">
          —
         </span>
         Any patient with recurrent pneumothorax (even in the contralateral lung) should undergo a definitive procedure since the likelihood of future events, particularly life-threatening ones, is high. (See
         <a class="local">
          'Incidence of recurrence'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H3080231908">
         <span class="h2">
          Concomitant indication for thoracoscopy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with hemothorax or need for lung biopsy may be considered for pleurodesis at the time of surgery. (See
         <a class="medical medical_review" href="/z/d/html/15141.html" rel="external">
          "Overview of minimally invasive thoracic surgery"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3890902759">
         <span class="h2">
          Other populations
         </span>
         <span class="headingEndMark">
          —
         </span>
         The risk of recurrence should be individualized in other patient populations (eg, trauma, iatrogenic). Among these causes, iatrogenic and traumatic pneumothorax are the most common, and a definitive procedure is
         <strong>
          not
         </strong>
         typically necessary unless a prolonged air leak develops. In contrast, patients with a structural abnormality that is irreversible, such as Marfan syndrome, may potentially benefit from definitive treatment to prevent recurrence. (See
         <a class="medical medical_review" href="/z/d/html/6691.html" rel="external">
          "Treatment of secondary spontaneous pneumothorax in adults", section on 'Other pneumothorax types'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6691.html" rel="external">
          "Treatment of secondary spontaneous pneumothorax in adults", section on 'Pneumothorax and pregnancy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4030818547">
         <span class="h2">
          Factors for decision-making
         </span>
         <span class="headingEndMark">
          —
         </span>
         Factors that should be taken into consideration that need discussion with the patient include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The assessed likelihood of recurrence and the risk at recurrence
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patient values and preferences
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ability to tolerate a surgical procedure (eg, surgery or conscious sedation)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Access to healthcare facility in the event of a recurrence
        </p>
        <p>
        </p>
        <p>
         The potential for lung transplantation is much higher in patients with SSP than PSP. Although pleurodesis can increase the morbidity associated with subsequent lung transplantation (eg, bleeding, requirement for transfusion, length of surgery), it should not affect the decision to proceed with the definitive intervention itself when indicated, but it may affect the type of definitive procedure chosen. (See
         <a class="local">
          'Pleurodesis'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H896168210">
         <span class="h1">
          DEFINITIVE MEASURES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Options for preventing recurrence include surgical and nonsurgical approaches:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In most cases, we prefer video-assisted thoracic surgery (VATS) pleurodesis based upon its high efficacy when compared with nonsurgical approaches. The chosen method of pleurodesis (eg, chemical, abrasion, pleurectomy) and the inclusion of a procedure to treat blebs (eg, stapling, ligation) is usually at the discretion of the surgeon, although we acknowledge that significant variability exists among institutions and countries. Medical thoracoscopy can allow talc poudrage but is unsuitable for treating underlying lung blebs and should only be considered if VATS is contraindicated. (See
         <a class="local">
          'Surgical candidates (VATS)'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/6699.html" rel="external">
          "Medical thoracoscopy (pleuroscopy): Diagnostic and therapeutic applications"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For those unable or unwilling to undergo VATS, chemical pleurodesis via chest tube is preferred. (See
         <a class="local">
          'Nonsurgical candidates (chemical pleurodesis)'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p>
         The choice of chemical sclerosing agent is highly variable among experts.
        </p>
        <p class="headingAnchor" id="H624439829">
         <span class="h2">
          Surgical candidates (VATS)
         </span>
         <span class="headingEndMark">
          —
         </span>
         In those with primary or secondary spontaneous pneumothorax with an indication for a definitive procedure, we suggest VATS based upon the high efficacy and lower adverse effect profile when compared with open thoracotomy [
         <a href="#rid16">
          16,21-34
         </a>
         ].
        </p>
        <p>
         Although pleurodesis via open thoracotomy has higher success rates, VATS has largely supplanted open thoracotomy for the management of spontaneous pneumothorax in most centers [
         <a href="#rid35">
          35,36
         </a>
         ]. Thoracotomy is recommended only if VATS is unavailable or has failed or in patients who desire the lowest level of recurrence risk (eg, high risk occupation) [
         <a href="#rid5">
          5
         </a>
         ]. This recommendation is based upon meta-analyses comparing open thoracotomy with VATS that have consistently shown lower recurrence rates with open procedures (approximately 1 percent with open versus 5 percent with VATS) but with greater blood loss, more postoperative pain, and longer hospital stays [
         <a href="#rid5">
          5,37,38
         </a>
         ].
        </p>
        <p>
         The two most common procedures that are performed during surgical thoracoscopy are pleurodesis and blebectomy/bullectomy. Many surgeons choose to perform both at the time of surgery since some data suggest that the recurrence rate is lower when both procedures are performed simultaneously. However, some surgeons perform pleurodesis without blebectomy/bullectomy or vice versa based upon data that suggest combining both procedures worsens the adverse effects. We prefer combining blebectomy/bullectomy with pleurodesis since it makes biologic sense that recurrence is lower when both procedures are used.
        </p>
        <p>
         Limited data report no difference in pneumothorax recurrence, length of hospital stay, need for further treatment, duration of air leak, complications, or mortality following bullectomy or surgical pleurodesis [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2889210534">
         <span class="h3">
          Pleurodesis
         </span>
         <span class="headingEndMark">
          —
         </span>
         We prefer mechanical pleurodesis using pleural abrasion with dry gauze as the initial procedure, since it is both simple and effective. Talc is associated with high success rates, and should be included in those considered at highest risk of recurrence or those with recalcitrant pneumothorax in whom avoidance of recurrence is critical. In patients considered at high risk of recurrence, some surgeons also choose to combine an apical pleurectomy (ie, partial pleurectomy to the region of lung most affected by blebs) with abrasion to the visceral pleura over the rest of the lung. (See
         <a class="local">
          'Talc'
         </a>
         below.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Techniques
         </strong>
         – Several surgical techniques have been reported to induce pleural symphysis (ie, pleurodesis) with significant variation in practice among surgeons, institutions, and countries. These include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Parietal or full pleurectomy (usually unilateral, occasionally bilateral) [
         <a href="#rid14">
          14,39-41
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Intrapleural insufflation of talc or a
         <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">
          tetracycline
         </a>
         derivative (ie, chemical pleurodesis) [
         <a href="#rid42">
          42
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pleural abrasion to visceral and parietal pleura with dry gauze [
         <a href="#rid43">
          43
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Laser abrasion of the parietal pleura [
         <a href="#rid44">
          44,45
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cellulose mesh with fibrin glue [
         <a href="#rid46">
          46,47
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Combinations of the above (eg, abrasion with partial pleurectomy and chemical pleurodesis)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Choosing a technique
         </strong>
         – Choosing among these options is often at the discretion of the surgeon but also dependent upon factors including the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Presenting manifestations of the patient (eg, severe, life-threatening symptoms versus asymptomatic)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Preferences and values of the patient
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Potential future need for lung transplantation
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Number of previous recurrences of pneumothorax
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Severity of underlying lung disease or burden of cysts
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Risk associated with VATS
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Previous pleurodesis
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         There is also considerable variability among countries, with mesh and fibrin glue being popular in Japan while mechanical abrasion or chemical pleurodesis is popular in the United States; similarly, talc is often the preferred sclerosant used in Europe, while a
         <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">
          tetracycline
         </a>
         derivative is preferred by some United States institutions.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Performing lung transplants in patients who have undergone pleurodesis is technically challenging and associated with increased blood loss due to dissection of the scarred pleural membrane. Although previous pleurodesis is not a contraindication for lung transplantation, we prefer a targeted/partial approach to pleurodesis in transplant candidates using VATS-directed closure of the site of air leak and/or blebectomy and consideration of mechanical abrasion of the apical pleural surface to achieve apical pleurodesis. This approach in theory provides enough pleurodesis to prevent large pneumothoraces while avoiding the formation of dense thick pleural symphysis, typical of chemical pleurodesis, which can be difficult to dissect. When feasible, we avoid full pleurodesis with chemicals, unless the frequency and degree of recurrence indicates the need for more aggressive measures (eg, bilateral life-threatening recurrence, recalcitrant pneumothorax) [
         <a href="#rid48">
          48
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4658.html" rel="external">
          "Lung transplantation: General guidelines for recipient selection", section on 'Previous cardiothoracic surgery'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H933550533">
         <span class="h3">
          Bleb/bulla closure
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although ill-defined, blebs are considered “blisters” that are visible to the naked eye on the surface of the pleura (typically 1 to 2 cm in size) while bullae are typically intraparenchymal and &gt;1 cm in size, often large. Consistent with the practice of many surgeons, we suggest VATS apical blebectomy/bullectomy simultaneously with pleurodesis based upon retrospective data that report recurrence rates &lt;5 percent using this combined approach [
         <a href="#rid26">
          26,38,49-51
         </a>
         ]. However, data are conflicting and some surgeons perform pleurodesis alone based upon data that report lower recurrence rates in patients with VATS-directed insufflation of talc compared with bullectomy alone (0.3 versus 3.8 percent) [
         <a href="#rid16">
          16,52
         </a>
         ], while others perform blebectomy/bullectomy alone based upon data that report recurrence rates &lt;9 percent with bullectomy alone [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p>
         The rationale for blebectomy/bullectomy is that patients with secondary spontaneous pneumothorax (SSP) and, less often, patients with primary spontaneous pneumothorax (PSP), have underlying subpleural blebs or bullae (cysts ≥1 cm) that are considered the most likely cause of spontaneous pneumothorax.
        </p>
        <p>
         Blebs/bullae are typically apical in location. While some defects (with or without air leaks) are visible to the naked eye (or on imaging), others are not apparent. Thus, many surgeons choose to resect the apex of the lung based upon the observation that even in the absence of obvious blebs/bullae, patients with pneumothorax have subclinical blebs noted on pathologic analysis of resected tissue. In support, many high grade blebs have been detected by fluorescein-enhanced autofluorescence thoracoscopy (FEAT) in areas that appear normal during white light thoracoscopy [
         <a href="#rid54">
          54
         </a>
         ]. When blebs or bullae are so numerous that resection of all blebs is not feasible, the surgeon may choose to resect only those that are large and leave smaller ones intact before proceeding with pleurodesis.
        </p>
        <p>
         The optimal surgical technique to treat underlying blebs/bullae is uncertain and, in most cases, the decision is typically left to the discretion and experience of the surgeon. In our experience, most surgeons resect blebs/bullae using a stapling technique since data support low recurrence rates with stapling [
         <a href="#rid50">
          50
         </a>
         ], and both pneumostasis and hemostasis can be achieved with this method. Other techniques include suturing, staple reinforcement at the suture line, ligation, or coagulation of visible lesions. (See
         <a class="medical medical_review" href="/z/d/html/1441.html" rel="external">
          "Bullectomy for giant bullae"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2291238061">
         <span class="h3">
          Lung volume reduction
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with emphysema who meet inclusion and exclusion criteria for lung volume reduction surgery (LVRS), it may be appropriate to perform LVRS at the time of surgical pleurodesis. (See
         <a class="medical medical_review" href="/z/d/html/1430.html" rel="external">
          "Lung volume reduction surgery in COPD", section on 'Patient selection'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H362475611">
         <span class="h2">
          Nonsurgical candidates (chemical pleurodesis)
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients who are unable or unwilling to undergo VATS or medical thoracoscopy, we suggest intrapleural injection of a chemical irritant, either graded talc or a
         <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">
          tetracycline
         </a>
         derivative (
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         or
         <a class="drug drug_general" data-topicid="9653" href="/z/d/drug information/9653.html" rel="external">
          minocycline
         </a>
         ), if available [
         <a href="#rid5">
          5
         </a>
         ]. Other sclerosants have been used (eg, iodopovidone). Many experts, including contributors of this topic, prefer talc due to its consistent high efficacy, especially in malignant pleural effusion. However, there is evidence that graded talc, which is now available in the United States, rarely, causes lung injury due to the larger size of its particles compared with ungraded talc, which may ultimately minimize the most worrisome adverse effect of talc (ie, lung injury) [
         <a href="#rid55">
          55
         </a>
         ]. Regardless of the sclerosant chosen, chemical pleurodesis via tube thoracostomy is not as effective as VATS pleurodesis or pleurodesis with medical thoracoscopy since rates of recurrence are about 25 percent [
         <a href="#rid19">
          19,56
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1207601272">
         <span class="h3">
          Tetracycline derivatives
         </span>
         <span class="headingEndMark">
          —
         </span>
         Chemical pleurodesis with
         <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">
          tetracycline
         </a>
         derivatives decreases the recurrence rate of pneumothorax to rates as low as 13 percent (range 13 to 25 percent). In two large trials of 442 patients with PSP, pleurodesis with the intrapleural instillation of a tetracycline derivative (tetracycline or
         <a class="drug drug_general" data-topicid="9653" href="/z/d/drug information/9653.html" rel="external">
          minocycline
         </a>
         ) was compared with aspiration and drainage without pleurodesis [
         <a href="#rid19">
          19,57
         </a>
         ]. Over a one to five year follow-up period, the rates of recurrent PSP fell from 41 to 25 percent (tetracycline) in one study [
         <a href="#rid19">
          19
         </a>
         ] and from 33 to 13 percent (minocycline) in another study [
         <a href="#rid57">
          57
         </a>
         ]. In those that failed, thoracoscopic evaluation by VATS revealed loose intrapleural adhesions only, suggesting that an intense inflammatory response was not initiated in some patients at the outset.
        </p>
        <p>
         Other than postpleurodesis pain,
         <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">
          tetracycline
         </a>
         derivatives are well-tolerated. Respiratory failure due to an apparent allergic reaction to intrapleural instillation of
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         has been reported [
         <a href="#rid58">
          58
         </a>
         ]. Additional technical details regarding tetracycline derivative administration are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/6695.html" rel="external">
          "Chemical pleurodesis for the prevention of recurrent pleural effusion"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H488677862">
         <span class="h3">
          Talc
         </span>
         <span class="headingEndMark">
          —
         </span>
         Talc is a cheap sclerosant that induces an intense inflammatory response.
         <a class="drug drug_general" data-topicid="9496" href="/z/d/drug information/9496.html" rel="external">
          Talc pleurodesis
         </a>
         is the most commonly preferred sclerosant in Europe but is also used frequently in the United States. Talc is consistently, among studies and in all populations, an effective sclerosant. In patients with PSP, recurrence rates vary between 2 and 8 percent after medical thoracoscopy, a rate that reflects that seen in other populations.
        </p>
        <p>
         Several studies support the safety and efficacy of
         <a class="drug drug_general" data-topicid="9496" href="/z/d/drug information/9496.html" rel="external">
          talc pleurodesis
         </a>
         for the prevention of recurrent pneumothorax, when
         <strong>
          graded
         </strong>
         talc is chosen [
         <a href="#rid30">
          30,59-61
         </a>
         ]. However, most data are derived from patients with malignant pleural effusion rather than pneumothorax and delivery is thoracoscopic rather than via a chest tube thoracotomy.
        </p>
        <p>
         However, intrapleural injection of talc has been associated with more adverse effects than
         <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">
          tetracycline
         </a>
         (tachycardia, fever, pain, respiratory failure). For example, the development of the acute respiratory failure/acute respiratory distress syndrome (ARDS) has been reported in 0 to 3.8 percent of patients and, although some cases are transient, other rare cases may be fatal [
         <a href="#rid62">
          62-66
         </a>
         ]. Small retrospective studies have suggested that small particle size, old age, and interstitial abnormalities may increase the risk of ARDS, although not all data were derived in patients with pneumothorax [
         <a href="#rid67">
          67,68
         </a>
         ]. Another case of extensive pleural thickening with calcifications has also been reported [
         <a href="#rid69">
          69
         </a>
         ]. Further details regarding
         <a class="drug drug_general" data-topicid="9496" href="/z/d/drug information/9496.html" rel="external">
          talc pleurodesis
         </a>
         are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/6695.html" rel="external">
          "Chemical pleurodesis for the prevention of recurrent pleural effusion"
         </a>
         .)
        </p>
        <p>
         There exists concerns that talc already creates an intense pleural reaction thus combination with other methods of pleurodesis (eg, abrasion) is unnecessary. In addition, concerns exist in using talc in those with significant intraparenchymal disease burden, who may not have significant reserve to tolerate an episode of ARDS or respiratory failure. There are insufficient data to support or disprove these concerns at present.
        </p>
        <p class="headingAnchor" id="H181408645">
         <span class="h3">
          Others
         </span>
         <span class="headingEndMark">
          —
         </span>
         One study reported similar efficacy between iodopovidone and talc when delivered thoracoscopically [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p>
         Limited data suggest that autologous blood patches may help to stop air leak and shortens length of stay [
         <a href="#rid5">
          5
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/116036.html" rel="external">
          "Alveolopleural fistula and prolonged air leak in adults", section on 'Autologous blood patch pleurodesis'
         </a>
         .)
        </p>
        <p>
         Bronchoscopic measures, such as endobronchial valve placement, may also be useful in patients not suited for surgery. Further details are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/116036.html" rel="external">
          "Alveolopleural fistula and prolonged air leak in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/116036.html" rel="external">
          "Alveolopleural fistula and prolonged air leak in adults", section on 'Bronchoscopic interventions'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H615250278">
         <span class="h2">
          Timing
         </span>
         <span class="headingEndMark">
          —
         </span>
         When a definitive procedure is indicated, it is usually performed during the same hospitalization (three to five days), since the risk of recurrence is greatest in the first month, although this is not always feasible.
        </p>
        <p class="headingAnchor" id="H375283856">
         <span class="h1">
          POSTPLEURODESIS PAIN
         </span>
         <span class="headingEndMark">
          —
         </span>
         Despite the intrapleural administration of anesthetic (eg,
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         ) preprocedurally, moderate to severe pain is a common complication after pleurodesis that may last for two weeks, sometimes longer [
         <a href="#rid59">
          59,71,72
         </a>
         ]. It generally dissipates slowly (weeks to months). Although the pain can arise from ongoing pleural inflammation, chronic post-thoracoscopy intercostal neuralgia is common with prevalence reported as high as 40 percent, and half of these cases are neuropathic in character. (See
         <a class="medical medical_review" href="/z/d/html/2804.html" rel="external">
          "Overview of cancer pain syndromes", section on 'Postsurgical pain syndromes'
         </a>
         .)
        </p>
        <p>
         Importantly, the severity of the pain is often underestimated by physicians. Accordingly, postoperative pain should be addressed in institutional protocols. Frequently, narcotic medication is needed in the short-term. Nonsteroidal agents were avoided in the immediate postoperative period since it was thought that nonsteroidal anti-inflammatory drugs (NSAIDs) might interfere with the inflammation that is required to ensure effective pleural membrane symphysis. However, a study comparing opioids with NSAIDs for pain reported no difference in the efficacy of pleurodesis in patients with malignant pleural effusion [
         <a href="#rid73">
          73
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6695.html" rel="external">
          "Chemical pleurodesis for the prevention of recurrent pleural effusion"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4235800360">
         <span class="h1">
          FOLLOW-UP
         </span>
         <span class="headingEndMark">
          —
         </span>
         Following a definitive procedure, the chest tube remains in place and patients are assessed daily for pain and for closure of the air leak. Frequent radiographs or ultrasonograms are performed to check for lung expansion. (See
         <a class="medical medical_review" href="/z/d/html/126624.html" rel="external">
          "Thoracostomy tubes and catheters: Management and removal", section on 'Management of thoracostomy tubes'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H848362928">
         <span class="h2">
          Sealed air leak
         </span>
         <span class="headingEndMark">
          —
         </span>
         Once the air leak has been sealed, the chest tube can be removed, and the patient can be discharged and followed up in an outpatient clinic, similar to that described elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/117232.html" rel="external">
          "Treatment of primary spontaneous pneumothorax in adults", section on 'Follow-up thoracostomy management (one to five days)'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/117232.html" rel="external">
          "Treatment of primary spontaneous pneumothorax in adults", section on 'Outpatient follow-up and management'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2148158833">
         <span class="h2">
          Prolonged air leak or refractory pneumothorax
         </span>
         <span class="headingEndMark">
          —
         </span>
         If an air leak persists or pneumothorax recurs despite pleurodesis, management may be complex due to loculations from the previous attempt at pleurodesis. In such cases, a multidisciplinary approach is advised where discussion of several options should be undertaken, including catheter-directed pleurodesis, thoracoscopic revision, placement of endobronchial valves, or conservative management. A rare patient is left with residual chronic pneumothorax.
        </p>
        <p class="headingAnchor" id="H2992129122">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/118533.html" rel="external">
          "Society guideline links: Pneumothorax"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2545711408">
         <span class="h1">
          PATIENT INFORMATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/16960.html" rel="external">
          "Patient education: Pneumothorax (collapsed lung) (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4204496184">
         <span class="h1">
          PATIENT PERSPECTIVE TOPIC
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patient perspectives are provided for selected disorders to help clinicians better understand the patient experience and patient concerns. These narratives may offer insights into patient values and preferences not included in other UpToDate topics. (See
         <a class="medical medical_review" href="/z/d/html/131727.html" rel="external">
          "Patient perspective: Lymphangioleiomyomatosis (LAM)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2851443018">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Incidence
         </strong>
         – Primary spontaneous pneumothorax (PSP) presents in the absence of clinical lung disease, while secondary spontaneous pneumothorax (SSP) presents as a complication of underlying lung disease  (
         <a class="graphic graphic_table graphicRef120903" href="/z/d/graphic/120903.html" rel="external">
          table 1
         </a>
         ). Recurrence rates vary but, in general, the risk of recurrence is higher with SSP (&gt;30 to 50 percent) than with PSP (10 to 30 percent). (See
         <a class="local">
          'Introduction'
         </a>
         above and
         <a class="local">
          'Incidence of recurrence'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Indications
         </strong>
         – Once patients have undergone initial management, clinicians should assess the risk of recurrence to evaluate whether definitive management is indicated. Indications include patients with PSP assessed to be at high risk of recurrence, patients with high risk professions or hobbies (eg, airplane pilot or deep sea diver), patients with a prolonged (persistent) air leak (typically &gt;5 days), patients with SSP or recurrent pneumothorax, or patients with a concomitant indication for thoracoscopy (eg, hemothorax or lung biopsy)  (
         <a class="graphic graphic_algorithm graphicRef121365" href="/z/d/graphic/121365.html" rel="external">
          algorithm 1
         </a>
         ). (See
         <a class="local">
          'Indications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Type of approach
         </strong>
         – For most patients in whom a definitive procedure is indicated, we recommend surgical approaches rather than nonsurgical approaches (
         <a class="grade" href="https:///uptodate/show/grade_2" rel="external">
          Grade 1B
         </a>
         ). This preference is based upon the high efficacy of surgery in this population who are at a high risk of recurrence.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Among the available surgical approaches, we suggest video-assisted thoracic surgery (VATS) rather than open thoracotomy due to the shorter length of hospital stay and lower morbidity (pain and blood loss) associated with VATS (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). (See
         <a class="local">
          'Surgical candidates (VATS)'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The method of pleurodesis (chemical sclerosant, abrasion, pleurectomy, mesh, fibrin glue, combinations) and the inclusion of a procedure to treat blebs/bullae (eg, apical resection, stapling, ligation, suturing, coagulation) is usually at the discretion of the surgeon and dependent upon presenting features of the patient, patient preferences, future need for lung transplantation, number of previous recurrences, severity of underlying disease, and surgical risk. We prefer VATS pleurodesis with dry gauze abrasion, stapling of blebs/bullae or talc insufflation, which are associated with the highest success rates, especially in those considered at highest risk of recurrence or those with recalcitrant pneumothorax in whom avoidance of recurrence is critical. (See
         <a class="local">
          'Pleurodesis'
         </a>
         above and
         <a class="local">
          'Bleb/bulla closure'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For patients in whom a definitive procedure is indicated who are poor candidates for or are unwilling to undergo VATS, we suggest chemical pleurodesis via tube thoracostomy rather than tube thoracostomy drainage alone (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). This procedure reduces the recurrence rate to &lt;25 percent when a
         <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">
          tetracycline
         </a>
         compound is used as the sclerosant. Success may be higher when graded talc is used as the sclerosant; choosing the sclerosant is individualized and should weigh the risk of adverse effects against the efficacy. (See
         <a class="local">
          'Nonsurgical candidates (chemical pleurodesis)'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Postpleurodesis pain
         </strong>
         – Despite the intrapleural administration of anesthetic preprocedurally, moderate to severe thoracic pain (especially intercostal neuralgia) is a common complication after VATS pleurodesis that may last for two weeks or longer. (See
         <a class="local">
          'Postpleurodesis pain'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Follow-up
         </strong>
         – Our approach is the following (see
         <a class="local">
          'Follow-up'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/117232.html" rel="external">
          "Treatment of primary spontaneous pneumothorax in adults", section on 'Follow-up thoracostomy management (one to five days)'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/117232.html" rel="external">
          "Treatment of primary spontaneous pneumothorax in adults", section on 'Outpatient follow-up and management'
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Sealed – Once the air leak has been sealed, the chest tube can be removed, and the patient can be discharged and followed up in outpatient clinic.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Prolonged air leak – However, if an air leak persists or pneumothorax recurs despite pleurodesis, a multidisciplinary approach is advised where discussion of several options should be undertaken including catheter-directed pleurodesis, thoracoscopic revision, or conservative management. Rarely, some patients are left with residual chronic pneumothorax.
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Baumann MH, Strange C, Heffner JE, et al. Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement. Chest 2001; 119:590.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henry M, Arnold T, Harvey J, Pleural Diseases Group, Standards of Care Committee, British Thoracic Society. BTS guidelines for the management of spontaneous pneumothorax. Thorax 2003; 58 Suppl 2:ii39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tschopp JM, Bintcliffe O, Astoul P, et al. ERS task force statement: diagnosis and treatment of primary spontaneous pneumothorax. Eur Respir J 2015; 46:321.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goto T, Kadota Y, Mori T, et al. Video-assisted thoracic surgery for pneumothorax: republication of a systematic review and a proposal by the guideline committee of the Japanese association for chest surgery 2014. Gen Thorac Cardiovasc Surg 2015; 63:8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roberts ME, Rahman NM, Maskell NA, et al. British Thoracic Society Guideline for pleural disease. Thorax 2023; 78:s1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flume PA, Mogayzel PJ Jr, Robinson KA, et al. Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. Am J Respir Crit Care Med 2010; 182:298.
          </a>
         </li>
         <li class="breakAll">
          Light RW. Pleural Diseases, 6th ed, Lippincott, Williams and Wilkins, Philadelphia 2013.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Light RW. Management of spontaneous pneumothorax. Am Rev Respir Dis 1993; 148:245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kepka S, Dalphin JC, Parmentier AL, et al. Primary Spontaneous Pneumothorax Admitted in Emergency Unit: Does First Episode Differ from Recurrence? A Cross-Sectional Study. Can Respir J 2017; 2017:2729548.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hallifax RJ, Goldacre R, Landray MJ, et al. Trends in the Incidence and Recurrence of Inpatient-Treated Spontaneous Pneumothorax, 1968-2016. JAMA 2018; 320:1471.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walker SP, Bibby AC, Halford P, et al. Recurrence rates in primary spontaneous pneumothorax: a systematic review and meta-analysis. Eur Respir J 2018; 52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sadikot RT, Greene T, Meadows K, Arnold AG. Recurrence of primary spontaneous pneumothorax. Thorax 1997; 52:805.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Casali C, Stefani A, Ligabue G, et al. Role of blebs and bullae detected by high-resolution computed tomography and recurrent spontaneous pneumothorax. Ann Thorac Surg 2013; 95:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guo Y, Xie C, Rodriguez RM, Light RW. Factors related to recurrence of spontaneous pneumothorax. Respirology 2005; 10:378.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hofmann HS, Suttner T, Neu R, et al. Burden between Undersupply and Overtreatment in the Care of Primary Spontaneous Pneumothorax. Thorac Cardiovasc Surg 2018; 66:575.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cardillo G, Bintcliffe OJ, Carleo F, et al. Primary spontaneous pneumothorax: a cohort study of VATS with talc poudrage. Thorax 2016; 71:847.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheng YL, Huang TW, Lin CK, et al. The impact of smoking in primary spontaneous pneumothorax. J Thorac Cardiovasc Surg 2009; 138:192.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Light RW. Talc should not be used for pleurodesis. Am J Respir Crit Care Med 2000; 162:2024.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Light RW, O'Hara VS, Moritz TE, et al. Intrapleural tetracycline for the prevention of recurrent spontaneous pneumothorax. Results of a Department of Veterans Affairs cooperative study. JAMA 1990; 264:2224.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ueyama M, Asakura T, Morimoto K, et al. Pneumothorax associated with nontuberculous mycobacteria: A retrospective study of 69 patients. Medicine (Baltimore) 2016; 95:e4246.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hwong TM, Ng CS, Lee TW, et al. Video-assisted thoracic surgery for primary spontaneous hemopneumothorax. Eur J Cardiothorac Surg 2004; 26:893.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sawada S, Watanabe Y, Moriyama S. Video-assisted thoracoscopic surgery for primary spontaneous pneumothorax: evaluation of indications and long-term outcome compared with conservative treatment and open thoracotomy. Chest 2005; 127:2226.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ayed AK, Al-Din HJ. The results of thoracoscopic surgery for primary spontaneous pneumothorax. Chest 2000; 118:235.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freixinet JL, Canalís E, Juliá G, et al. Axillary thoracotomy versus videothoracoscopy for the treatment of primary spontaneous pneumothorax. Ann Thorac Surg 2004; 78:417.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Inderbitzi RG, Leiser A, Furrer M, Althaus U. Three years' experience in video-assisted thoracic surgery (VATS) for spontaneous pneumothorax. J Thorac Cardiovasc Surg 1994; 107:1410.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cardillo G, Facciolo F, Giunti R, et al. Videothoracoscopic treatment of primary spontaneous pneumothorax: a 6-year experience. Ann Thorac Surg 2000; 69:357.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hatz RA, Kaps MF, Meimarakis G, et al. Long-term results after video-assisted thoracoscopic surgery for first-time and recurrent spontaneous pneumothorax. Ann Thorac Surg 2000; 70:253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lang-Lazdunski L, de Kerangal X, Pons F, Jancovici R. Primary spontaneous pneumothorax: one-stage treatment by bilateral videothoracoscopy. Ann Thorac Surg 2000; 70:412.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Janssen JP, van Mourik J, Cuesta Valentin M, et al. Treatment of patients with spontaneous pneumothorax during videothoracoscopy. Eur Respir J 1994; 7:1281.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Györik S, Erni S, Studler U, et al. Long-term follow-up of thoracoscopic talc pleurodesis for primary spontaneous pneumothorax. Eur Respir J 2007; 29:757.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nathan DP, Taylor NE, Low DW, et al. Thoracoscopic total parietal pleurectomy for primary spontaneous pneumothorax. Ann Thorac Surg 2008; 85:1825.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rena O, Massera F, Papalia E, et al. Surgical pleurodesis for Vanderschueren's stage III primary spontaneous pneumothorax. Eur Respir J 2008; 31:837.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee S, Kim HR, Cho S, et al. Staple line coverage after bullectomy for primary spontaneous pneumothorax: a randomized trial. Ann Thorac Surg 2014; 98:2005.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Herrmann D, Klapdor B, Ewig S, Hecker E. Initial management of primary spontaneous pneumothorax with video-assisted thoracoscopic surgery: a 10-year experience. Eur J Cardiothorac Surg 2016; 49:854.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hazelrigg SR, Landreneau RJ, Mack M, et al. Thoracoscopic stapled resection for spontaneous pneumothorax. J Thorac Cardiovasc Surg 1993; 105:389.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Urschel JD. Thoracoscopic treatment of spontaneous pneumothorax. A review. J Cardiovasc Surg (Torino) 1993; 34:535.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barker A, Maratos EC, Edmonds L, Lim E. Recurrence rates of video-assisted thoracoscopic versus open surgery in the prevention of recurrent pneumothoraces: a systematic review of randomised and non-randomised trials. Lancet 2007; 370:329.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vohra HA, Adamson L, Weeden DF. Does video-assisted thoracoscopic pleurectomy result in better outcomes than open pleurectomy for primary spontaneous pneumothorax? Interact Cardiovasc Thorac Surg 2008; 7:673.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Waller DA, Yoruk Y, Morritt GN, et al. Videothoracoscopy in the treatment of spontaneous pneumothorax: An initial experience. Ann Royal College Surg Eng 1993; 75:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ayed AK. Suction versus water seal after thoracoscopy for primary spontaneous pneumothorax: prospective randomized study. Ann Thorac Surg 2003; 75:1593.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Qureshi R, Nugent A, Hayat J, et al. Should surgical pleurectomy for spontaneous pneumothorax be always thoracoscopic? Interact Cardiovasc Thorac Surg 2008; 7:569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Milanez JR, Vargas FS, Filomeno LT, et al. Intrapleural talc for the prevention of recurrent pneumothorax. Chest 1994; 106:1162.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fosse E, Fjeld NB, Brockmeier V, Buanes T. Thoracoscopic pleurodesis. Scand J Thorac Cardiovasc Surg 1993; 27:117.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Torre M, Grassi M, Nerli FP, et al. Nd-YAG laser pleurodesis via thoracoscopy. Endoscopic therapy in spontaneous pneumothorax Nd-YAG laser pleurodesis. Chest 1994; 106:338.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bobbio A, Ampollini L, Internullo E, et al. Thoracoscopic parietal pleural argon beam coagulation versus pleural abrasion in the treatment of primary spontaneous pneumothorax. Eur J Cardiothorac Surg 2006; 29:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sakamoto K, Takei H, Nishii T, et al. Staple line coverage with absorbable mesh after thoracoscopic bullectomy for spontaneous pneumothorax. Surg Endosc 2004; 18:478.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mizobuchi T, Kurihara M, Ebana H, et al. A total pleural covering of absorbable cellulose mesh prevents pneumothorax recurrence in patients with Birt-Hogg-Dubé syndrome. Orphanet J Rare Dis 2018; 13:78.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Noyes BE, Orenstein DM. Treatment of pneumothorax in cystic fibrosis in the era of lung transplantation. Chest 1992; 101:1187.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horowitz MD, Oliva H. Pneumothorax in AIDS patients: operative management. Am Surg 1993; 59:200.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Naunheim KS, Mack MJ, Hazelrigg SR, et al. Safety and efficacy of video-assisted thoracic surgical techniques for the treatment of spontaneous pneumothorax. J Thorac Cardiovasc Surg 1995; 109:1198.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Asban A, Raza SS, McLeod C, et al. Mechanical or chemical and mechanical pleurodesis for spontaneous pneumothorax: what is the most effective approach in preventing recurrence? A systematic review and meta-analysis. Eur J Cardiothorac Surg 2020; 58:682.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wait MA, Dal Nogare AR. Treatment of AIDS-related spontaneous pneumothorax. A decade of experience. Chest 1994; 106:693.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nakayama T, Takahashi Y, Uehara H, et al. Outcome and risk factors of recurrence after thoracoscopic bullectomy in young adults with primary spontaneous pneumothorax. Surg Today 2017; 47:859.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Noppen M, Dekeukeleire T, Hanon S, et al. Fluorescein-enhanced autofluorescence thoracoscopy in patients with primary spontaneous pneumothorax and normal subjects. Am J Respir Crit Care Med 2006; 174:26.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Janssen JP, Collier G, Astoul P, et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 2007; 369:1535.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alfageme I, Moreno L, Huertas C, et al. Spontaneous pneumothorax. Long-term results with tetracycline pleurodesis. Chest 1994; 106:347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen JS, Tsai KT, Hsu HH, et al. Intrapleural minocycline following simple aspiration for initial treatment of primary spontaneous pneumothorax. Respir Med 2008; 102:1004.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DiBardino DJ, Vanatta JM, Fagan SP, Awad SS. Acute respiratory failure after pleurodesis with doxycycline. Ann Thorac Surg 2002; 74:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tschopp JM, Boutin C, Astoul P, et al. Talcage by medical thoracoscopy for primary spontaneous pneumothorax is more cost-effective than drainage: a randomised study. Eur Respir J 2002; 20:1003.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cardillo G, Carleo F, Carbone L, et al. Long-term lung function following videothoracoscopic talc poudrage for primary spontaneous recurrent pneumothorax. Eur J Cardiothorac Surg 2007; 31:802.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hunt I, Barber B, Southon R, Treasure T. Is talc pleurodesis safe for young patients following primary spontaneous pneumothorax? Interact Cardiovasc Thorac Surg 2007; 6:117.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Campos JR, Vargas FS, de Campos Werebe E, et al. Thoracoscopy talc poudrage : a 15-year experience. Chest 2001; 119:801.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brant A, Eaton T. Serious complications with talc slurry pleurodesis. Respirology 2001; 6:181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pletinckx P, Muysoms F, De Decker C, et al. Thoracoscopic talc pleurodesis for the treatment of spontaneous pneumothorax. Acta Chir Belg 2005; 105:504.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gonzalez AV, Bezwada V, Beamis JF Jr, Villanueva AG. Lung injury following thoracoscopic talc insufflation: experience of a single North American center. Chest 2010; 137:1375.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bridevaux PO, Tschopp JM, Cardillo G, et al. Short-term safety of thoracoscopic talc pleurodesis for recurrent primary spontaneous pneumothorax: a prospective European multicentre study. Eur Respir J 2011; 38:770.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shinno Y, Kage H, Chino H, et al. Old age and underlying interstitial abnormalities are risk factors for development of ARDS after pleurodesis using limited amount of large particle size talc. Respirology 2018; 23:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leuzzi G, Vita ML, Porziella V, et al. Single center experience on talc poudrage morbidity: focus on high talc dosage. J Cardiothorac Surg 2011; 6:87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lange P, Mortensen J, Groth S. Lung function 22-35 years after treatment of idiopathic spontaneous pneumothorax with talc poudrage or simple drainage. Thorax 1988; 43:559.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Agarwal R, Paul AS, Aggarwal AN, et al. A randomized controlled trial of the efficacy of cosmetic talc compared with iodopovidone for chemical pleurodesis. Respirology 2011; 16:1064.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khoshbin E, Prayaga S, Kinsella J, Sutherland FW. Mini-sternotomy for aortic valve replacement reduces the length of stay in the cardiac intensive care unit: meta-analysis of randomised controlled trials. BMJ Open 2011; 1:e000266.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khoshbin E, Al-Jilaihawi AN, Scott NB, et al. An audit of pain control pathways following video-assisted thoracoscopic surgery. Innovations (Phila) 2011; 6:248.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rahman NM, Pepperell J, Rehal S, et al. Effect of Opioids vs NSAIDs and Larger vs Smaller Chest Tube Size on Pain Control and Pleurodesis Efficacy Among Patients With Malignant Pleural Effusion: The TIME1 Randomized Clinical Trial. JAMA 2015; 314:2641.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 117888 Version 16.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11171742" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12728149" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : BTS guidelines for the management of spontaneous pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26113675" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : ERS task force statement: diagnosis and treatment of primary spontaneous pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25182971" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Video-assisted thoracic surgery for pneumothorax: republication of a systematic review and a proposal by the guideline committee of the Japanese association for chest surgery 2014.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37433578" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : British Thoracic Society Guideline for pleural disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20675678" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20675678" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8317808" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Management of spontaneous pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28465661" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Primary Spontaneous Pneumothorax Admitted in Emergency Unit: Does First Episode Differ from Recurrence? A Cross-Sectional Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30304427" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Trends in the Incidence and Recurrence of Inpatient-Treated Spontaneous Pneumothorax, 1968-2016.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30002105" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Recurrence rates in primary spontaneous pneumothorax: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9371212" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Recurrence of primary spontaneous pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22785214" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Role of blebs and bullae detected by high-resolution computed tomography and recurrent spontaneous pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15955153" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Factors related to recurrence of spontaneous pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29290080" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Burden between Undersupply and Overtreatment in the Care of Primary Spontaneous Pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27422793" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Primary spontaneous pneumothorax: a cohort study of VATS with talc poudrage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19577078" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : The impact of smoking in primary spontaneous pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11112104" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Talc should not be used for pleurodesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2214100" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Intrapleural tetracycline for the prevention of recurrent spontaneous pneumothorax. Results of a Department of Veterans Affairs cooperative study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27442650" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Pneumothorax associated with nontuberculous mycobacteria: A retrospective study of 69 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15519178" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Video-assisted thoracic surgery for primary spontaneous hemopneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15947341" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Video-assisted thoracoscopic surgery for primary spontaneous pneumothorax: evaluation of indications and long-term outcome compared with conservative treatment and open thoracotomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10893385" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : The results of thoracoscopic surgery for primary spontaneous pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15276488" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Axillary thoracotomy versus videothoracoscopy for the treatment of primary spontaneous pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8196381" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Three years' experience in video-assisted thoracic surgery (VATS) for spontaneous pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10735663" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Videothoracoscopic treatment of primary spontaneous pneumothorax: a 6-year experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10921718" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Long-term results after video-assisted thoracoscopic surgery for first-time and recurrent spontaneous pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10969654" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Primary spontaneous pneumothorax: one-stage treatment by bilateral videothoracoscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7925907" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Treatment of patients with spontaneous pneumothorax during videothoracoscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17182650" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Long-term follow-up of thoracoscopic talc pleurodesis for primary spontaneous pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18442607" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Thoracoscopic total parietal pleurectomy for primary spontaneous pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18057049" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Surgical pleurodesis for Vanderschueren's stage III primary spontaneous pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25443007" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Staple line coverage after bullectomy for primary spontaneous pneumothorax: a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26094014" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Initial management of primary spontaneous pneumothorax with video-assisted thoracoscopic surgery: a 10-year experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8445917" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Thoracoscopic stapled resection for spontaneous pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8300723" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Thoracoscopic treatment of spontaneous pneumothorax. A review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17662881" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Recurrence rates of video-assisted thoracoscopic versus open surgery in the prevention of recurrent pneumothoraces: a systematic review of randomised and non-randomised trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18287119" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Does video-assisted thoracoscopic pleurectomy result in better outcomes than open pleurectomy for primary spontaneous pneumothorax?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Videothoracoscopy in the treatment of spontaneous pneumothorax: An initial experience
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12735584" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Suction versus water seal after thoracoscopy for primary spontaneous pneumothorax: prospective randomized study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18407960" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Should surgical pleurectomy for spontaneous pneumothorax be always thoracoscopic?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7924490" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Intrapleural talc for the prevention of recurrent pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8197424" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Thoracoscopic pleurodesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7774298" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Nd-YAG laser pleurodesis via thoracoscopy. Endoscopic therapy in spontaneous pneumothorax Nd-YAG laser pleurodesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16337391" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Thoracoscopic parietal pleural argon beam coagulation versus pleural abrasion in the treatment of primary spontaneous pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14752657" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Staple line coverage with absorbable mesh after thoracoscopic bullectomy for spontaneous pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29764481" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : A total pleural covering of absorbable cellulose mesh prevents pneumothorax recurrence in patients with Birt-Hogg-Dubésyndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1582268" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Treatment of pneumothorax in cystic fibrosis in the era of lung transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8476161" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Pneumothorax in AIDS patients: operative management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7776683" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Safety and efficacy of video-assisted thoracic surgical techniques for the treatment of spontaneous pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32463893" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Mechanical or chemical and mechanical pleurodesis for spontaneous pneumothorax: what is the most effective approach in preventing recurrence? A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8082341" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Treatment of AIDS-related spontaneous pneumothorax. A decade of experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27909813" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Outcome and risk factors of recurrence after thoracoscopic bullectomy in young adults with primary spontaneous pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16627865" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Fluorescein-enhanced autofluorescence thoracoscopy in patients with primary spontaneous pneumothorax and normal subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17482984" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7774300" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Spontaneous pneumothorax. Long-term results with tetracycline pleurodesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18457940" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Intrapleural minocycline following simple aspiration for initial treatment of primary spontaneous pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12118779" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Acute respiratory failure after pleurodesis with doxycycline.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12412696" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Talcage by medical thoracoscopy for primary spontaneous pneumothorax is more cost-effective than drainage: a randomised study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17336083" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Long-term lung function following videothoracoscopic talc poudrage for primary spontaneous recurrent pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17669785" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Is talc pleurodesis safe for young patients following primary spontaneous pneumothorax?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11243960" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Thoracoscopy talc poudrage : a 15-year experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11555375" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Serious complications with talc slurry pleurodesis
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16315834" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Thoracoscopic talc pleurodesis for the treatment of spontaneous pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20097802" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Lung injury following thoracoscopic talc insufflation: experience of a single North American center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21436351" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Short-term safety of thoracoscopic talc pleurodesis for recurrent primary spontaneous pneumothorax: a prospective European multicentre study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28980363" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Old age and underlying interstitial abnormalities are risk factors for development of ARDS after pleurodesis using limited amount of large particle size talc.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21707987" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Single center experience on talc poudrage morbidity: focus on high talc dosage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3212753" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Lung function 22-35 years after treatment of idiopathic spontaneous pneumothorax with talc poudrage or simple drainage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21605278" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : A randomized controlled trial of the efficacy of cosmetic talc compared with iodopovidone for chemical pleurodesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22116090" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Mini-sternotomy for aortic valve replacement reduces the length of stay in the cardiac intensive care unit: meta-analysis of randomised controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22437983" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : An audit of pain control pathways following video-assisted thoracoscopic surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26720026" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Effect of Opioids vs NSAIDs and Larger vs Smaller Chest Tube Size on Pain Control and Pleurodesis Efficacy Among Patients With Malignant Pleural Effusion: The TIME1 Randomized Clinical Trial.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
